20 Views
1
Nts whose relapse was treated with first-line tamoxifen monotherapy. These patients had not received (neo) adjuvant endocrine systemic treatment. In univariate analyses, no statistically significant associations were observed between DC-SCRIPT as transformed continuous variable and PFS or clinical benefit after start of first-line treatment with tamoxifen (HR = 1.08 [0.99 to 1.18], P = 0.07 and od

Comments

Who Upvoted this Story

Most Viewed Stories
Statistics